FOOSE BRICE sold 330K shares of INVIVO THERAPEUTICS HOLDINGS CORP. on the open market
Open‑market sale worth $123.0K. Review remaining holdings and any 10b5‑1 plan disclosures.
InVivo Therapeutics Holdings Corp
Shares
−37K
Price / share
$0.31
Trade value
$11.47K
% of position
InVivo Therapeutics Holdings Corp
Shares
−20K
Price / share
$0.32
Trade value
$6.40K
% of position
InVivo Therapeutics Holdings Corp
Shares
−13K
Price / share
$0.30
Trade value
$3.90K
% of position
InVivo Therapeutics Holdings Corp
Shares
−48K
Price / share
$0.28
Trade value
$13.44K
% of position
InVivo Therapeutics Holdings Corp
Shares
−12K
Price / share
$0.25
Trade value
$3K
% of position
InVivo Therapeutics Holdings Corp
Shares
−36K
Price / share
$0.26
Trade value
$9.36K
% of position
InVivo Therapeutics Holdings Corp
Shares
−8K
Price / share
$0.34
Trade value
$2.72K
% of position
InVivo Therapeutics Holdings Corp
Shares
−33K
Price / share
$0.35
Trade value
$11.55K
% of position
InVivo Therapeutics Holdings Corp
Shares
−35K
Price / share
$0.36
Trade value
$12.60K
% of position
InVivo Therapeutics Holdings Corp
Shares
−37K
Price / share
$0.50
Trade value
$18.50K
% of position
InVivo Therapeutics Holdings Corp
Shares
−51K
Price / share
$0.59
Trade value
$30.09K
% of position
Net shares
−330K
Net value
-$123.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| InVivo Therapeutics Holdings Corp Direct | 2/5/2023 | P · Purchase | −37K | $0.31 | $11.47K | 11.2% | 330K | 293K |
| InVivo Therapeutics Holdings Corp Direct | 2/5/2023 | P · Purchase | −20K | $0.32 | $6.40K | 6.8% | 293K | 273K |
| InVivo Therapeutics Holdings Corp Direct | 2/5/2023 | P · Purchase | −13K | $0.30 | $3.90K | 4.8% | 273K | 260K |
| InVivo Therapeutics Holdings Corp Direct | 2/5/2023 | P · Purchase | −48K | $0.28 | $13.44K | 18.5% | 260K | 212K |
| InVivo Therapeutics Holdings Corp Direct | 2/5/2023 | P · Purchase | −12K | $0.25 | $3K | 5.7% | 212K | 200K |
| InVivo Therapeutics Holdings Corp Direct | 2/5/2023 | P · Purchase | −36K | $0.26 | $9.36K | 18.0% | 200K | 164K |
| InVivo Therapeutics Holdings Corp Direct | 2/6/2023 | P · Purchase | −8K | $0.34 | $2.72K | 4.9% | 164K | 156K |
| InVivo Therapeutics Holdings Corp Direct | 2/6/2023 | P · Purchase | −33K | $0.35 | $11.55K | 21.2% | 156K | 123K |
| InVivo Therapeutics Holdings Corp Direct | 2/6/2023 | P · Purchase | −35K | $0.36 | $12.60K | 28.5% | 123K | 88K |
| InVivo Therapeutics Holdings Corp Direct | 2/6/2023 | P · Purchase | −37K | $0.50 | $18.50K | 42.0% | 88K | 51K |
| InVivo Therapeutics Holdings Corp Direct | 2/6/2023 | P · Purchase | −51K | $0.59 | $30.09K | New position | 51K | 0.00 |
| Total | −330K | -$123.03K | ||||||